$KULR

NLR Battery Innovation Awarded NASA’s Invention of the Year

NASA awarded the 2025 Invention of the Year to a technology developed by the U.S. Department of Energy’s National Laboratory of the Rockies (NLR) and partner KULR Technology Group. The internal short-circuit device (ISC-D) is implanted in lithium-ion cells to trigger controlled internal failures and improve thermal runaway testing for Artemis missions, according to NASA and NLR.

Original reporting
Published Jul 16, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NLR Battery Innovation Awarded NASA’s Invention of the Year — source image
Decision brief

The 30-second read

$KULRBullishLow
01

Why it matters

The article frames ISC-D as enabling repeatable verification that spacecraft batteries resist thermal runaway propagation, with KULR moving from licensing to delivering pre-implanted cells.

02

Market read

Credibility boost for battery safety testing tech used in manned spacecraft, but no new financial or procurement details are provided.

03

What to watch

Traders may overestimate award-driven catalysts without accompanying procurement announcements, manufacturing scale-up details, or updated financial guidance.

Relevance 4/10Novelty 4/10Timing: award recognition reported today, no new financial disclosures

Background

NASA’s Artemis II used lithium-ion batteries, and NLR developed an internal short-circuit device (ISC-D) to trigger controlled internal failures for testing.

Company-level read

Ticker impact

$KULRBullishLow confidence
Context

NASA’s 2025 Invention of the Year recognizes NLR’s internal short-circuit device, with KULR Technology Group as the industry partner and licensee.

Expected impact

Likely limited near-term impact; any effect would be sentiment/credibility rather than a measurable earnings catalyst.

Evidence & confidence

The piece is an award/technology validation story. It does not disclose revenue, new orders, funding, or guidance, so tradable magnitude is uncertain.

Market effects

Highlights demand for safer lithium-ion testing methods for space and high-reliability battery systems, supportive for battery safety and thermal management suppliers.

No clear regional market linkage beyond US space/DOE/NASA ecosystem.

Space-grade battery safety standards and testing methods can influence global aerospace supply chains, but the article does not quantify adoption.

Counterpoint

An award does not guarantee near-term revenue; KULR’s embedded-cell delivery may already be in progress, limiting incremental impact.

Key entities

  • NLR (National Laboratory of the Rockies)

    DOE-affiliated lab collaborating with NASA on battery safety testing via ISC-D.

  • KULR Technology Group

    Industry partner and technology licensee delivering ISC-D-embedded cells for product-level testing.

  • NASA

    Awarded the 2025 Invention of the Year for the ISC-D-based innovation.

Related articles

$KULRMed

KULR Technology Group, Inc. (KULR): Completion of Acquisition or Disposition of Assets

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01 Completion of Acquisition or Disposition of Assets During the period from August 20, 2026 through September 11, 2026, KULR Technology Group, Inc. (“KULR” or the “Company”) sold an aggregate of approximately 764 bitcoin (“BTC”) through a series of open market transaction

$KULRMed

KULR Technology Group, Inc. (KULR): Results of Operations and Financial Condition

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 KULR Technology Group Reports Second Quarter 2026 Financial Results HOUSTON / GLOBENEWSWIRE / August 13, 2026 / KULR Technology Group, Inc . (NYSE American: KULR) (the "Company" or "KULR"), a developer of safe, high-power energy systems that enable physical AI across

$KULRMed

KULR Technology Group, Inc. (KULR): Completion of Acquisition or Disposition of Assets

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001662684 0001662684 2026-07-20 2026-07-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earli

$AZNMedAI 8/10

AZN Looks 12.0% Undervalued on GF Value™ as Dividend Remains Att

AstraZeneca (AZN) reported that its SERENA-4 Phase III trial for Etcamah did not meet its primary endpoint but showed clinical benefits in a specific breast cancer subgroup. The company offers a 2.05% dividend yield with a 47% payout ratio, and its stock is considered 12.0% undervalued based on a GF Value™ of $182.10. AstraZeneca has a GF Score™ of 77, indicating strong fundamentals. Institutional interest is mixed, with 8 gurus adding and 7 trimming positions. Insider sales totaled $2.2 million

$IONSHighAI 9/10

Ionis Has Its First Neurology Launch, But Can Zanvastro Justify Its $285,000 Price?

Ionis Pharmaceuticals (IONS) launched Zanvastro, the first FDA-approved treatment for Alexander disease, priced at $285,000 per dose. The company expects peak annual sales over $100M. The drug showed efficacy in clinical trials, but its high cost, small patient population, and invasive administration pose challenges. Analysts see potential for Ionis' broader neurology pipeline.